free tracking Antibiotics Market to Exhibit a CAGR of 2.1% by 2027; Rising Incidence of Tuberculosis and Malaria to Spur Lucrative Opportunities - Given Take Business
Have any questions:

Mail to guestpostingbloggers@gmail.com

Antibiotics Market to Exhibit a CAGR of 2.1% by 2027; Rising Incidence of Tuberculosis and Malaria to Spur Lucrative Opportunities

performance measurement tools 
In: Business, Health

The global “Antibiotics market” size is expected to reach USD 39.06 billion in 2027 at a CAGR of 2.1% during the forecast period. The increasing R&D for the development of antimicrobials in multidrug-resistant bacteria is expected to have a tremendous impact on the global market, states Fortune Business Insights, in a report, titled “Antibiotics Market Size, Share & Industry Analysis, By Drug Class (Cephalosporin, Penicillins, Fluoroquinolones, Macrolides, and Others), By Route of Administration (Oral and Parenteral) By End User (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size stood at USD 43.30 billion in 2019.

Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/sample/antibiotics-market-104583

Market Driver:

Increasing Cases of Bacterial Infections to Boost Market

The increasing cases of bacterial infections will spur demand for antimicrobials, which, in turn, will augur well for the market. The rising incidence of tuberculosis, malaria, pneumonia, bacterial skin infections, urinary tract infections (UTI), and others will bolster the market’s healthy growth during the forecast period. As per the estimates of WHO, the worldwide prevalence of tuberculosis was 10 million in 2019. According to the Centers for Disease Control and Prevention, 1.7 million HAIs occur every year in the U.S., 32% of which are hospital-acquired UTIs. The increasing government efforts to prevent hospital-acquired infections (HAI), catheter, and ventilator-associated infections will create lucrative opportunities for the market in the forthcoming years.

The report on the antibiotics market discloses:

  • Eminent insights into the industry
  • Important data with in-depth research
  • Factors exhibiting market growth
  • Comprehensive study about main regions
  • COVID-19 impact on the market
  • Prime developments in the industry

Regional Analysis:

Heavy Demand for Antibiotics to Contribute Growth in Asia Pacific

The market in Asia Pacific is expected to hold the largest share during the forecast period due to the high consumption of antibiotics. According to an article published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), China, India, and Pakistan witnessed a rise of 103%, 79%, and 69%, respectively, in antibiotic consumption during 2000-2015. The growing prevalence of bacterial infections coupled with the high use of antimicrobials will spur lucrative opportunities for the Asia Pacific market.

Also Read:

Germany Hepatitis C Testing Market

The Report Lists the Key Players in the Antibiotics Market:

  • Pfizer Inc. (New York, U.S.)
  • GlaxoSmithKline plc (Brentford, U.K.)
  • Merck & Co., Inc. (New Jersey, U.S.)
  • Sandoz (Novartis AG) (Holzkirchen, Germany)
  • Daiichi Sankyo Company, Limited (Tokyo, Japan)
  • Taisho Pharmaceutical Holdings (Tokyo, Japan)
  • Melinta Therapeutics (New Jersey, U.S.)
  • Other Prominent Players

Leave a Reply

Your email address will not be published.

Ready to Grow Your Business?

We Serve our Clients’ Best Interests with the Best Marketing Solutions. Find out More